Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone Effect on Atherogenesis in Healthy Males
NCT03367663Phase 1Completed
- Start
- Jan 2018
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of prednisone in atherosclerosis (2 arms). Primary endpoint: Serum atherogenicity at 3 months. Started Jan 2018; status: completed.
02
Drugs
prednisone
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT03367663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03367663.